Ireland - English - HPRA (Health Products Regulatory Authority)

wockhardt uk limited - pamidronic acid - concentrate for solution for infusion - 15 milligram(s)/millilitre - bisphosphonates; pamidronic acid

Ireland - English - HPRA (Health Products Regulatory Authority)

wockhardt uk limited - pamidronic acid - concentrate for solution for infusion - 15 milligram(s)/millilitre - bisphosphonates; pamidronic acid

Ireland - English - HPRA (Health Products Regulatory Authority)

wockhardt uk limited - pamidronic acid - concentrate for solution for infusion - 15 milligram(s)/millilitre - bisphosphonates; pamidronic acid

Ireland - English - HPRA (Health Products Regulatory Authority)

wockhardt uk limited - pamidronic acid - concentrate for solution for infusion - 15 milligram(s)/millilitre - bisphosphonates; pamidronic acid

New Zealand - English - Medsafe (Medicines Safety Authority)

boucher & muir (new zealand) limited t/a bnm group - pamidronic acid 12.63mg equivalent to 15 mg disodium pamidronate - solution for infusion - 15 mg/5ml - active: pamidronic acid 12.63mg equivalent to 15 mg disodium pamidronate excipient: mannitol phosphoric acid sodium hydroxide water for injection - treatment of conditions associated with increased osteoclast activity: · predominantly lytic bone metastases from breast cancer and advanced multiple myeloma

New Zealand - English - Medsafe (Medicines Safety Authority)

boucher & muir (new zealand) limited t/a bnm group - pamidronic acid 25.27mg equivalent to 30 mg disodium pamidronate - solution for infusion - 30 mg/10ml - active: pamidronic acid 25.27mg equivalent to 30 mg disodium pamidronate excipient: mannitol phosphoric acid sodium hydroxide water for injection - treatment of conditions associated with increased osteoclast activity: · predominantly lytic bone metastases from breast cancer and advanced multiple myeloma

New Zealand - English - Medsafe (Medicines Safety Authority)

boucher & muir (new zealand) limited t/a bnm group - pamidronic acid 50.54mg equivalent to 60 mg disodium pamidronate - solution for infusion - 60 mg/10ml - active: pamidronic acid 50.54mg equivalent to 60 mg disodium pamidronate excipient: mannitol phosphoric acid sodium hydroxide water for injection - treatment of conditions associated with increased osteoclast activity: · predominantly lytic bone metastases from breast cancer and advanced multiple myeloma

New Zealand - English - Medsafe (Medicines Safety Authority)

boucher & muir (new zealand) limited t/a bnm group - pamidronic acid 75.82mg equivalent to 90 mg disodium pamidronate - solution for infusion - 90 mg/10ml - active: pamidronic acid 75.82mg equivalent to 90 mg disodium pamidronate excipient: mannitol phosphoric acid sodium hydroxide water for injection - treatment of conditions associated with increased osteoclast activity: · predominantly lytic bone metastases from breast cancer and advanced multiple myeloma

Ireland - English - HPRA (Health Products Regulatory Authority)

pinewood laboratories ltd, - pamidronic acid - concentrate for solution for infusion - 15 milligram(s)/millilitre - bisphosphonates; pamidronic acid

Ireland - English - HPRA (Health Products Regulatory Authority)

pinewood laboratories ltd, - pamidronic acid - concentrate for solution for infusion - 15 milligram(s)/millilitre - bisphosphonates; pamidronic acid